ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Cancer Prevention Fellowship Program

April 28, 2000

Research Needed On Hormonally Active Agents, Report Finds

August 6, 1999

CTEP Director Friedman Adds To Article On Minority Initiative

March 23, 1990

Medicare Should Pay Routine Care For Patients in Trials: IOM.

January 7, 2000

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

March 8, 1985